An Open label, Multicentre, Phase I study of Ibrutinib, Rituximab and EBV specific T-cells in Patients with EBV-positive Primary or Secondary CNS Lymphoma unsuitable for standard therapies (2018-2025)

Professor Maher Gandhi

Affiliate of Centre for Extracellular Vesicle Nanomedicine

Centre for Extracellular Vesicle Nanomedicine

Faculty of Health, Medicine and Behavioural Sciences

Honorary Professor

Mater Research Institute-UQ

Faculty of Health, Medicine and Behavioural Sciences

Associate Professor Colm Keane

Principal Research Fellow

Frazer Institute

Faculty of Health, Medicine and Behavioural Sciences